Dow [DOW] vs Asp Isotopes [ASPI] Detailed Stock Comparison
Dow
NYSE
Loading...
Asp Isotopes
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Dow wins in 9 metrics, Asp Isotopes wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Dow | Asp Isotopes | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 75.93 | -14.17 | Asp Isotopes |
| Price-to-Book Ratio | 0.90 | 15.14 | Dow |
| Debt-to-Equity Ratio | 97.39 | 84.08 | Asp Isotopes |
| PEG Ratio | 7.01 | -59.53 | Asp Isotopes |
| EV/EBITDA | 8.33 | -23.83 | Asp Isotopes |
| Profit Margin (TTM) | -2.35% | 38.60% | Asp Isotopes |
| Operating Margin (TTM) | 0.21% | -721.89% | Dow |
| EBITDA Margin (TTM) | 0.21% | N/A | N/A |
| Return on Equity | -4.74% | -115.46% | Dow |
| Return on Assets (TTM) | 1.06% | -26.14% | Dow |
| Free Cash Flow (TTM) | $-151.00M | $-28.07M | Asp Isotopes |
| 1-Year Return | -58.10% | 313.43% | Asp Isotopes |
| Price-to-Sales Ratio (TTM) | 0.37 | 185.28 | Dow |
| Enterprise Value | $32.17B | $666.51M | Dow |
| EV/Revenue Ratio | 0.77 | 151.29 | Dow |
| Gross Profit Margin (TTM) | 5.77% | 29.67% | Asp Isotopes |
| Revenue per Share (TTM) | $59 | $0 | Dow |
| Earnings per Share (Diluted) | $-1.40 | $-0.59 | Asp Isotopes |
| Beta (Stock Volatility) | 0.86 | 3.38 | Dow |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Dow vs Asp Isotopes Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Dow | -6.44% | -14.58% | -21.70% | -28.63% | -41.71% | -44.91% |
| Asp Isotopes | -1.54% | -14.71% | 27.57% | 65.37% | 55.30% | 80.77% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Dow | -58.10% | -57.68% | -48.89% | -52.11% | -14.35% | -53.85% |
| Asp Isotopes | 313.43% | 218.93% | 218.93% | 218.93% | 218.93% | 218.93% |
Performance & Financial Health Analysis: Dow vs Asp Isotopes
| Metric | DOW | ASPI |
|---|---|---|
| Market Information | ||
| Market Cap | $15.45B | $816.25M |
| Market Cap Category | Large cap | Small cap |
| 10 Day Avg. Volume | 23,408,010 | 4,793,356 |
| 90 Day Avg. Volume | 17,118,143 | 4,457,119 |
| Last Close | $21.79 | $8.93 |
| 52 Week Range | $21.79 - $55.67 | $1.86 - $10.82 |
| % from 52W High | -60.86% | -17.47% |
| All-Time High | $71.86 (Apr 18, 2022) | $10.82 (Jul 25, 2025) |
| % from All-Time High | -69.68% | -17.47% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.07% | 0.31% |
| Quarterly Earnings Growth | -0.07% | 0.31% |
| Financial Health | ||
| Profit Margin (TTM) | -0.02% | 0.39% |
| Operating Margin (TTM) | 0.00% | -7.22% |
| Return on Equity (TTM) | -0.05% | -1.15% |
| Debt to Equity (MRQ) | 97.39 | 84.08 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $24.31 | $0.59 |
| Cash per Share (MRQ) | $3.86 | $0.75 |
| Operating Cash Flow (TTM) | $1.24B | $-16,894,872 |
| Levered Free Cash Flow (TTM) | $-748,625,024 | $-20,013,620 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Dow vs Asp Isotopes
| Metric | DOW | ASPI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 75.93 | -14.17 |
| Forward P/E | 7.01 | -59.53 |
| PEG Ratio | 7.01 | -59.53 |
| Price to Sales (TTM) | 0.37 | 185.28 |
| Price to Book (MRQ) | 0.90 | 15.14 |
| Market Capitalization | ||
| Market Capitalization | $15.45B | $816.25M |
| Enterprise Value | $32.17B | $666.51M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.77 | 151.29 |
| Enterprise to EBITDA | 8.33 | -23.83 |
| Risk & Other Metrics | ||
| Beta | 0.86 | 3.38 |
| Book Value per Share (MRQ) | $24.31 | $0.59 |
Financial Statements Comparison: Dow vs Asp Isotopes
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | DOW | ASPI |
|---|---|---|
| Revenue/Sales | $10.43B | $1.10M |
| Cost of Goods Sold | $9.76B | $774,765 |
| Gross Profit | $671.00M | $326,840 |
| Research & Development | $200.00M | $1.53M |
| Operating Income (EBIT) | $29.00M | $-7.95M |
| EBITDA | $820.00M | $-8.23M |
| Pre-Tax Income | $-374.00M | $-8.53M |
| Income Tax | $-84.00M | $-70,720 |
| Net Income (Profit) | $-290.00M | $-8.46M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | DOW | ASPI |
|---|---|---|
| Cash & Equivalents | $1.47B | $55.97M |
| Total Current Assets | $16.33B | $59.03M |
| Total Current Liabilities | $10.59B | $8.18M |
| Long-Term Debt | $16.95B | $36.96M |
| Total Shareholders Equity | $17.30B | $45.73M |
| Retained Earnings | $20.10B | $-64.62M |
| Property, Plant & Equipment | $64.56B | $1.02M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | DOW | ASPI |
|---|---|---|
| Operating Cash Flow | $30.00M | $-7.16M |
| Capital Expenditures | $3.00M | $-2.36M |
| Free Cash Flow | $-594.00M | $-5.53M |
| Debt Repayment | $-964.00M | $-262,304 |
| Common Stock Repurchase | $0 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | DOW | ASPI |
|---|---|---|
| Shares Short | 31.63M | 16.34M |
| Short Ratio | 2.21 | 4.67 |
| Short % of Float | 0.05% | 0.24% |
| Average Daily Volume (10 Day) | 23,408,010 | 4,793,356 |
| Average Daily Volume (90 Day) | 17,118,143 | 4,457,119 |
| Shares Outstanding | 703.61M | 72.07M |
| Float Shares | 707.00M | 54.53M |
| % Held by Insiders | 0.00% | 0.23% |
| % Held by Institutions | 0.68% | 0.37% |
Dividend Analysis & Yield Comparison: Dow vs Asp Isotopes
| Metric | DOW | ASPI |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |